Fenyveslitke, Hungary

Karol Gyure

This inventor holds 2 USPTO granted patents. Top assignees: Aktiebolaget Astra, Astra Aktiebolag. Active years: 1996-1997.


% Patents Active = 100.0

Average Co-Inventor Count = 23.0

ph-index = 1


Company Filing History:


Years Active: 1996-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Karol Gyure

Introduction

Karol Gyure is a notable inventor based in Fenyveslitke, Hungary. He has made significant contributions to the field of chemistry, particularly in the preparation of specialized compounds. With a total of 2 patents to his name, Gyure's work showcases his expertise and innovative spirit.

Latest Patents

Gyure's latest patents include a process for the preparation of 4-methyl-5-(2-chloroethyl)-thiazole. This invention relates to a method for synthesizing compounds characterized by specific chemical structures. The process involves reacting a 3,5-dichloro-2-alkanone with an inorganic thiocyamate, leading to the formation of various thiazole derivatives. His detailed methodology highlights the intricate steps involved in achieving the desired chemical transformations.

Career Highlights

Throughout his career, Karol Gyure has worked with prominent companies such as Astra Aktiebolag and Aktiebolaget Astra. His experience in these organizations has contributed to his development as an inventor and has provided him with valuable insights into the pharmaceutical industry.

Collaborations

Gyure has collaborated with notable colleagues, including Csaba Gonczi and Csaba Huszar. These partnerships have likely enriched his research and innovation efforts, fostering a collaborative environment for scientific advancement.

Conclusion

Karol Gyure's contributions to the field of chemistry through his patents and collaborations reflect his dedication to innovation. His work continues to influence the development of new compounds and processes in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…